產品簡介
?
???????LipoFiterTM?脂質體轉染試劑(LipoFiterTM?Liposomal?Transfection?Reagent?)是一種適合于把質?;蚱渌问降暮怂?以及核酸蛋白復合物轉染到培養的真核細胞中的高效陽離子脂質體轉染試劑。
?
???????漢恒生物獨立研發的?LipoFiterTM?脂質體轉染試劑具有轉染效率高,重復性好,操作簡單,無明顯細胞毒性,抗血清干擾等優點,用LipoFiterTM?轉染細胞后,對于大多數細胞,72小時內不更換培養液無明顯細胞毒性。使用LipoFiterTM?轉染時血清的存在不影響轉染效率,這樣可以減小去除血清對細胞的損傷。
?
??? LipoFiterTM?對于貼壁細胞和懸浮細胞都適用,并且可以用于穩定表達細胞株的篩選。
?
??????????????
?
產品編號 | 產品名稱 | 產品規格 | 官方售價 |
HB-TRLF-50 | LipoFiter轉染試劑 | 50ul | 試用裝 |
HB-TRLF-1000 | LipoFiter轉染試劑 | 1ml | ¥1180 |
?
?
?
?
產品優勢
?
1. ?轉染效率高
2. ?細胞毒性低
3. ?生物穩定性高
4. ?適用范圍廣泛
5. ?不受有無血清及抗生素的影響
6. ?重復性高、可操作性強
?
?
已驗證細胞
?
細胞名稱 | LipofiterTM轉染效率 |
HEK293 | 90%~95% |
293-T | 90%~95% |
AD293 | 90%~95% |
293FT | 80%~95% |
Hela | 90%~95% |
Hep3B | 70%~80% |
hUCMSCs | 60%~70% |
HMSCs | 60%~70% |
NIH/3T3 | 60%~70% |
?
?
毒性測試
?

?
?
實驗圖片
?
hep3B:

?
?
HEK293:

? ? ? ? ? ? ? ?
hela:

?
NIH3T3:
?

?
LipoFiterTM的參考文獻:
?
1、 Low expression of TRAF3IP2-AS1 promotes progression of NONO-TFE3 translocation renal cell carcinoma by stimulating N6-methyladenosine of PARP1 mRNA and downregulating PTEN
? ?(2021年發表于Journal of Hematology&Oncology,IF=17.384)
?
2、Switch receptor T3/28 improves long-term persistence and antitumor efficacy of CAR-T cells
? (2021年發表于Journal for ImmunoTherapy of Cancer, IF=13.751)
?
3、Positive natural selection of N6-methyladenosine on the RNAs of processed pseudogenes
? ?(2021年發表于Genome Biology, IF=13.583)
?
4、TRIM24 facilitates antiviral immunity through mediating K63-linked TRAF3 ubiquitination
? ?(2020年發表于Journal of Experimental Medicine, IF=11.743)
5、Targeting miR-21 with NL101 blocks c-Myc/Mxd1 loop and inhibits the growth of B cell lymphoma
? ?(2021年發表于Theranostics,IF=11.556)
6、Tubular epithelial cell-to-macrophage communication forms a negative feedback loop via extracellular vesicle transfer to promote renal inflammation and apoptosis in diabetic nephropathy
? ?(2022年發表于Theranostics,IF=11.556)
7、N6-methyladenosine-induced circ1662 promotes metastasis of colorectal cancer by accelerating YAP1 nuclear localization
? ?(2021年發表于Theranostics,IF=11.556)
8、Expression and mechanism of exosome-mediated A FOXM1 related long noncoding RNA in gastric cancer
?(2021年發表于Journal of Nanobiotechnology,IF=10.431)
?
?